Visit JCR Japan

Visit JCR Japan

Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us

Copyright 2025, JCR Pharmaceuticals Co., Ltd. All Rights Reserved

JCR Pharmaceuticals announces the achievement of enrollment in the JR-141 global phase III clinical trial

July 2, 2025

|In News

|By Moises Zanetti

Back to Newsroom

Sitemap
Compliance
Privacy policy
Global policy
Cookie policy
Cookie settings

Copyright 2025, JCR Pharmaceuticals Co., Ltd. All Rights Reserved

Privacy Preference Center

Privacy Preferences